BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8948026)

  • 1. Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties.
    Freedman MH; Hitzler JK; Bunin N; Grunberger T; Squire J
    Stem Cells; 1996 Nov; 14(6):690-701. PubMed ID: 8948026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia.
    Freedman MH; Cohen A; Grunberger T; Bunin N; Luddy RE; Saunders EF; Shahidi N; Lau A; Estrov Z
    Br J Haematol; 1992 Jan; 80(1):40-8. PubMed ID: 1311195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.
    Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M
    Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
    Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH
    Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
    Lapidot T; Grunberger T; Vormoor J; Estrov Z; Kollet O; Bunin N; Zaizov R; Williams DE; Freedman MH
    Blood; 1996 Oct; 88(7):2655-64. PubMed ID: 8839860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
    Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
    Cancer Res; 1993 Jan; 53(2):401-9. PubMed ID: 7678076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
    Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
    Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular characteristics of chronic myelocytic leukemia basophilic crisis cells: phenotype, responsiveness to and receptor gene expression for various kinds of growth factors and cytokines.
    Shimizu N; Kita K; Masuya M; Nishii K; Matsuoka N; Morita N; Miwa H; Shirakawa S
    Exp Hematol; 1993 Jan; 21(1):119-25. PubMed ID: 7678084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human granulocyte-macrophage colony-stimulating factor supports the clonogenic growth of B-lineage acute lymphoblastic leukemias expressing myeloid antigens.
    Gattei V; Aldinucci D; Attadia V; Degan M; Alosi MS; De Iuliis A; Babare R; Rossi FM; Rupolo M; Zagonel V; Pinto A
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):141-51. PubMed ID: 9426972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
    Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
    Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation.
    Zecca M; Rosti V; Pinto L; Comoli P; Carrà AM; Prete L; Bonetti F; Pedrazzoli P; Locatelli F; Cazzola M
    Med Pediatr Oncol; 1995 Mar; 24(3):166-70. PubMed ID: 7838038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin enhances the production of myeloid cells, but not megakaryocytes, in juvenile chronic myelogenous leukemia.
    Sawai N; Koike K; Higuchi T; Ogami K; Oda M
    Blood; 1998 Jun; 91(11):4065-73. PubMed ID: 9596651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of fibroblast-like cells from CD34(+) progenitor cells of the bone marrow in rheumatoid arthritis.
    Hirohata S; Yanagida T; Nagai T; Sawada T; Nakamura H; Yoshino S; Tomita T; Ochi T
    J Leukoc Biol; 2001 Sep; 70(3):413-21. PubMed ID: 11527991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell culture studies and oncogene expression in juvenile chronic myelogenous leukemia.
    Gualtieri RJ; Castleberry RP; Gibbons J; Miller DM; Berkow RL; Parmley RT; Banks J
    Exp Hematol; 1988 Aug; 16(7):613-9. PubMed ID: 2968914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR
    Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.